Display options
Cite
Pritchett AM, Mann DL. Neurohormonal Therapy for Congestive Heart Failure. Curr Treat Options Cardiovasc Med. 2004;6(6):499-507doi: 10.1007/s11936-004-0007-6.
Pritchett, A. M., & Mann, D. L. (2004). Neurohormonal Therapy for Congestive Heart Failure. Current treatment options in cardiovascular medicine, 6(6), 499-507. https://doi.org/10.1007/s11936-004-0007-6
Pritchett, Allison M, and Mann, Douglas L. "Neurohormonal Therapy for Congestive Heart Failure." Current treatment options in cardiovascular medicine vol. 6,6 (2004): 499-507. doi: https://doi.org/10.1007/s11936-004-0007-6
Pritchett AM, Mann DL. Neurohormonal Therapy for Congestive Heart Failure. Curr Treat Options Cardiovasc Med. 2004 Dec;6(6):499-507. doi: 10.1007/s11936-004-0007-6. PMID: 15496267.
Copy Download .nbib Format: NLM
Share it on

Curr Treat Options Cardiovasc Med. 2004 Dec;6(6):499-507. doi: 10.1007/s11936-004-0007-6.

Neurohormonal Therapy for Congestive Heart Failure.

Current treatment options in cardiovascular medicine

Allison M Pritchett, Douglas L Mann

PMID: 15496267 DOI: 10.1007/s11936-004-0007-6

Abstract

Guidelines for heart failure management have been published by the American College of Cardiology and the American Heart Association in 2001. These guidelines recommend the use of angiotensin-converting enzyme inhibitors and beta blockers to improve the symptoms and prognosis of heart failure. Despite being advocated as the cornerstone of medical management, these agents remain underutilized. Not only are these drugs underutilized, but titration to dosages with proven beneficial effects is lacking. Simply achieving widespread usage of these agents would have a significant impact on heart failure outcomes.

References

  1. J Am Coll Cardiol. 1992 Jul;20(1):248-54 - PubMed
  2. Am J Cardiol. 1993 Mar 25;71(9):3C-11C - PubMed
  3. Lancet. 1979 Jun 30;1(8131):1374-6 - PubMed
  4. Am J Physiol. 1988 Aug;255(2 Pt 2):H261-5 - PubMed
  5. Ann Intern Med. 2002 Nov 5;137(9):715-25 - PubMed
  6. Lancet. 1998 Aug;352 Suppl 1:SI29-33 - PubMed
  7. Am J Cardiol. 1990 Dec 1;66(19):1348-54 - PubMed
  8. N Engl J Med. 2000 Jul 27;343(4):246-53 - PubMed
  9. JAMA. 1995 May 10;273(18):1450-6 - PubMed
  10. N Engl J Med. 2003 Apr 3;348(14):1309-21 - PubMed
  11. J Am Coll Cardiol. 2001 Dec;38(7):2101-13 - PubMed
  12. J Card Fail. 2004 Apr;10(2):115-9 - PubMed
  13. N Engl J Med. 1987 Jun 4;316(23 ):1429-35 - PubMed
  14. J Am Coll Cardiol. 1997 Sep;30(3):725-32 - PubMed
  15. JAMA. 2004 Apr 28;291(16):2017-8 - PubMed
  16. Prog Cardiovasc Dis. 1998 Jul-Aug;41(1 Suppl 1):1-8 - PubMed
  17. J Am Coll Cardiol. 2000 Nov 1;36(5):1706-12 - PubMed
  18. N Engl J Med. 1991 Nov 21;325(21):1468-75 - PubMed
  19. Lancet. 2003 Sep 6;362(9386):759-66 - PubMed
  20. Am J Cardiol. 1991 Jan 1;67(1):67-73 - PubMed
  21. N Engl J Med. 1992 Sep 3;327(10):669-77 - PubMed
  22. Eur Heart J. 1996 Nov;17(11):1629-39 - PubMed
  23. JAMA. 2002 Mar 27;287(12):1531-40 - PubMed
  24. Lancet. 2003 Jul 5;362(9377):7-13 - PubMed
  25. JAMA. 2004 Apr 28;291(16):1963-71 - PubMed
  26. N Engl J Med. 1999 Sep 2;341(10):709-17 - PubMed
  27. Br Heart J. 1975 Oct;37(10 ):1022-36 - PubMed
  28. Circulation. 2001 Dec 11;104(24):2996-3007 - PubMed
  29. Lancet. 2003 Sep 6;362(9386):767-71 - PubMed
  30. J Am Coll Cardiol. 1999 Jul;34(1):155-62 - PubMed
  31. Circulation. 1999 Sep 7;100(10):1056-64 - PubMed
  32. N Engl J Med. 2002 May 2;346(18):1357-65 - PubMed
  33. Circulation. 2001 Nov 13;104(20):2417-23 - PubMed
  34. Lancet. 2002 Nov 23;360(9346):1631-9 - PubMed
  35. N Engl J Med. 1991 Aug 1;325(5):293-302 - PubMed
  36. Heart. 2000 Dec;84(6):615-9 - PubMed
  37. Lancet. 1993 Dec 11;342(8885):1441-6 - PubMed
  38. Eur J Pharmacol. 2000 Mar 10;391(1-2):39-48 - PubMed

Publication Types